Early research (Phase 1)UnknownNCT05798533What this trial is testingNeo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)Who this might be right forSolid Tumor BGI, China 6
Not applicableUnknownNCT04436406What this trial is testingPD-L1 Expression in Cancer (PECan Study).Who this might be right forNon-small Cell Lung CancerMelanoma Guy's and St Thomas' NHS Foundation Trust 30
Not applicableUnknownNCT00757614What this trial is testingStudy of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomWho this might be right forBladder CancerBrain and Central Nervous System TumorsEsophageal Cancer+6 more Cancer Research UK 14,000
Testing effectiveness (Phase 2)Looking for participantsNCT07718243What this trial is testingInvestigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLCWho this might be right forMelanoma (Skin Cancer)Non Small Cell Lung CancerSolid Tumor in Advanced Stage Institute of Cancer Research, United Kingdom 62
Early research (Phase 1)Ended earlyNCT05573035What this trial is testingInvestigate LYL845 in Adults With Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerColorectal Cancer Lyell Immunopharma, Inc. 39
Early research (Phase 1)Study completedNCT00526617What this trial is testingA Phase I Study of ABT-888 in Combination With Temozolomide in Cancer PatientsWho this might be right forNon-hematologic MalignanciesMetastatic MelanomaBreast Cancer+4 more AbbVie 41
Testing effectiveness (Phase 2)Study completedNCT02978404What this trial is testingCombining Radiosurgery and Nivolumab in the Treatment of Brain MetastasesWho this might be right forClear-Cell Metastatic Renal Cell CarcinomaNon Small Cell Lung Cancer MetastaticBrain Metastases, Adult+2 more Centre hospitalier de l'Université de Montréal (CHUM) 26
Testing effectiveness (Phase 2)Looking for participantsNCT07339176What this trial is testingIntratumoral N17350 in Advanced Solid TumorsWho this might be right forNeoplasms, Solid TumorBreast Neoplasms, Triple-NegativeSquamous Cell Carcinoma of Skin+4 more Onchilles Pharma Inc 275
Early research (Phase 1)Study completedNCT01131234What this trial is testingGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more National Cancer Institute (NCI) 20
Not applicableStudy completedNCT03946007What this trial is testingQuality of Life and Physical Fitness After Immune Checkpoint InhibitorsWho this might be right forMelanomaNon Small Cell Lung Cancer University Medical Center Groningen 134
Testing effectiveness (Phase 2)Looking for participantsNCT04851119What this trial is testingTegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsWho this might be right forColorectal CarcinomaEndometrial CarcinomaMelanoma+19 more Children's Oncology Group 147
Early research (Phase 1)Active Not RecruitingNCT03589339What this trial is testingNBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyWho this might be right forRadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more Nanobiotix 145
Not applicableLooking for participantsNCT05837767What this trial is testingRadiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueWho this might be right forInvasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more Memorial Sloan Kettering Cancer Center 26
Not applicableNot Yet RecruitingNCT07032701What this trial is testingA Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin CancerWho this might be right forSkin Carcinoma Jonsson Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT05914116What this trial is testingA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumors DualityBio Inc. 862
Early research (Phase 1)UnknownNCT04137900What this trial is testingSafety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced MalignanciesWho this might be right forAdvanced Unresectable Solid TumorMetastatic Solid Tumor TopAlliance Biosciences 499
Not applicableStudy completedNCT04146064What this trial is testingBreathomics as Predictive Biomarker for Checkpoint Inhibitor ResponseWho this might be right forNSCLCMelanomaKidney Cancer+2 more University Health Network, Toronto 190
Testing effectiveness (Phase 2)Ended earlyNCT05709821What this trial is testingIMM60 and Pembrolizumab in Melanoma and NSCLCWho this might be right forNon-small Cell Lung CancerMelanoma iOx Therapeutics 1
Testing effectiveness (Phase 2)Ended earlyNCT03277352What this trial is testingINCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic MalignanciesWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 10
Testing effectiveness (Phase 2)Ended earlyNCT04198818What this trial is testingEvaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced TumorsWho this might be right forAdvanced TumorsMelanomaNon-Small-Cell Lung Cancer+2 more Haihe Biopharma Co., Ltd. 37